ConductScience.org, home

Paper33398166

Targeting the mitochondria to block tumour growth.

Crunkhorn S. Nat Rev Drug Discov, 2021. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Targeting the mitochondria to block tumour growth. Papers, record 33398166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33398166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting the mitochondria to block tumour growth.
PubMed
Journal
Nat Rev Drug Discov
PubMed
Year
2021
PubMed
Publication types
Journal Article, Comment
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.4
iCite
Revised in PubMed
2026-10-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Crunkhorn SSarah

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA, MitochondrialMajor topic
NeoplasmsMajor topic
Humans
Mitochondria

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on33328633Small-molecule inhibitors of human mitochondrial DNA transcription.https://conductscience.org/library/papers/33328633

Source PubMed

Download CSV of comments and corrections

References1

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn Papers
133328633Small-molecule inhibitors of human mitochondrial DNA transcription.Nature2020https://conductscience.org/library/papers/33328633

Source PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
40249372Update on the correlation between mitochondrial function and osteonecrosis of the femoral head osteocytes.Redox Rep2025https://conductscience.org/library/papers/40249372PubMed
38654380Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer.J Transl Med2024https://conductscience.org/library/papers/38654380PubMed
37736880OXPHOS-targeting drugs in oncology: new perspectives.Expert Opin Ther Targets2023https://conductscience.org/library/papers/37736880PubMed
37142668Antiproliferative effects of mitochondria-targeted N-acetylcysteine and analogs in cancer cells.Sci Rep2023https://conductscience.org/library/papers/37142668PubMed
35756631Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities.Front Oncol2022https://conductscience.org/library/papers/35756631PubMed
35332210Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation.Sci Rep2022https://conductscience.org/library/papers/35332210PubMed
34976949Targeting Mitochondrial Metabolism and RNA Polymerase POLRMT to Overcome Multidrug Resistance in Cancer.Front Chem2021https://conductscience.org/library/papers/34976949PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33398166

GET https://conductscience.org/api/papers/v1/33398166/authors